Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
Nature Communications|May 9, 2025
BiDAC-dependent degradation of plasma membrane proteins by the endolysosomal systemSammy Villa, Qumber Jafri, Julia R Lazzari-Dean, et al.Cancer Research|July 5, 2002
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathwayPierre P Massion, Wen-Lin Kuo, David Stokoe, et al.Cell Reports|August 30, 2016
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human CancersLeonard D Goldstein, James Lee, Florian Gnad, et al.Cell|May 2, 2006
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signalingZachary A Knight, Beatriz Gonzalez, Morri E Feldman, et al.Molecular Cancer Research : MCR|April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypesXiaolan Hu, Howard M Stern, Lin Ge, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Tethering identifies fragment that yields potent inhibitors of human caspase-1Bruce T Fahr, Tom O'Brien, Phuongly Pham, et al.Cancer Research|April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genesGenee Y Lee, Peter M Haverty, Li Li, et al.Nature Medicine|December 13, 2006
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in gliomaAndrew T Parsa, James S Waldron, Amith Panner, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Identification of potent and novel small-molecule inhibitors of caspase-3Darin A Allen, Phuongly Pham, Ingrid C Choong, et al.Molecular Cancer Research : MCR|August 13, 2009
Oncogenic activating mutations are associated with local copy gainBarmak Modrek, Lin Ge, Ajay Pandita, et al.Pageof 11